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Most cases of autoinflammatory diseases (AIDs) are characterized by attacks of systemic inflammation 
resulting in recurrent fever, acute arthritis, and increased acute phase proteins. Frequent symptoms 
are also skin rash, myalgia, and bone deformations. The appropriate diagnosis of an AID can be chal-
lenging due to the overlapping symptoms or the presence of comorbidities, as autoimmune diseases. 
The discovery of the first autoinflammatory gene, MEFV, responsible for familial Mediterranean 
fever has dramatically increased the understanding of the pathophysiology of AIDs, shedding light 
on the associated defective signaling pathways (1). Since then, more than 20 autoinflammatory genes 
have been discovered, even though their clinical significance is often unclear. Moreover, an increasing 
number of reports describe cases bearing two mutations in a dominant-inherited AID, or patients 
with more than two mutations that segregate in a recessive AID, or mutated gene clusters. All these 
findings confuse the clinician leading to a delayed diagnosis or less accurate and relevant treatments.
The concept of autoinflammation originally emerged from the context of the monogenic 
hereditary periodic fever syndrome. Nowadays, it is worldwide accepted the hypothesis that AIDs 
are distributed along a continuum involving mutation type, number of genes, and environmental 
factors, ranging from monogenic to multifactorial conditions (2). An increasing number of studies 
support the involvement of sequence variants of gene responsible for Mendelian AIDs in multifacto-
rial conditions (3). An example should be the Crohn’s disease, one of the first investigated complex 
diseases in which NOD2 gene [responsible for Blau syndrome (BS)] was identified as a susceptibility 
gene. More recently, Jéru and colleagues describe the pathogenicity of a mutation affecting the same 
residue in TNFR1 in both Mendelian TRAPS syndrome and multifactorial inflammatory conditions 
(early arthritis, AA amyloidosis in juvenile idiopathic arthritis, multiple sclerosis, as examples) (4).
Thus, not only a single gene could be involved in various phenotypes but also many different genes 
could be entailed in overlapping phenotypes.
Consistent with this hypothesis, we propose that evolutionary gene duplication can have a causa-
tive role in AIDs development. Gene duplication is an important mechanism through which new 
genetic material is generated during molecular evolution. It can result from unequal crossing over, 
retroposition, or chromosomal/genome duplication (5). Duplication increases buffering capacity 
of genomes or species in adapting to changing environments, offering a selective advantage over 
a long-time scale. Functional redundancy resulting from gene duplication was reported to be a 
common phenomenon in biological systems by Podder and Ghosh (6). The assessment of the dif-
ferences between monogenic and polygenic disease genes revealed that monogenic disease genes 
are functionally more buffered by their duplicates than polygenic ones. It seems akin to the current 
puzzling genetic situation of the AIDs.
A computational study by Wong and co-authors (7) observed that almost 50% of the disease 
proteins in the Ensembl database have duplicates associated with disease, suggesting that gene dupli-
cation is a significant phenomenon to the expansion of disease-related protein family. This reinforces 
the concept that sequence similarity to known disease proteins may also be a significant factor that 
contributes to disease propensity and implies common origins and mechanisms to many diseases.
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We have focused our attention on the nucleotide-binding 
domain, leucine-rich repeat (LRR) (NLR)-containing family, 
important components of the innate immune system. Only a few 
members of this family, including the cytosolic pattern recogni-
tion receptors NOD2, nod-like receptor protein 3 (NLRP3), and 
NLRP12, have been analyzed extensively. These NLRs are known 
to have a pivotal role in the innate immune response toward 
microbial invasion and are identfied as responsible for clinical 
distinct AIDs, which shares pathophysiological characteristics (8).
Over the last decade, several mutations have been identified in 
NOD2 gene, encoding for the intracellular sensor of bacterial cell 
wall components (NOD2) that triggers the activation of NF-κB 
and MAPK pathways. NOD2 has a typical three-domain struc-
ture composed of two N-terminal effector regions consisting of a 
caspase recruitment domain, a centrally located domain NACHT 
that is critical for protein activation, and nine C-terminal LRRs 
that sense the pathogens. Mutations on LRRs are known to confer 
susceptibility to Crohn’s disease, a chronic inflammatory bowel 
disorder, whereas mutations in the central NACHT domain are 
associated with a granulomatous disease, named BS. BS is a rare 
autosomal dominant AID clinically characterized by granu-
lomatous recurrent uveitis, dermatitis, and symmetric arthritis 
(9). The most commonly observed BS-related mutations are 
high-penetrance missense substitutions affecting the highly evo-
lutionary conserved Arginine residue at position 334 (p.R334W 
or p.R334Q).
NLRP3 gene encodes a protein named cryopyrin or NLRP3, 
that comprise a N-terminal nucleotide-binding domain named 
pyrin, a central regulatory region NACHT and a C-terminal LRR 
domain. NLRP3, along with caspase-1 and an adaptor protein 
called ASC, was identified as a component of a cytoplasmic com-
plex named inflammasome. NALP3 inflammasome is activated 
by a variety of factors, acting as a general detector of cell stress 
from pathogenic infection and intrinsic metabolic compounds. 
This inflammasome fulfills several cellular functions, from the 
activation of appropriate inflammatory processes through inter-
leukin (IL)-1β to the activation of bacterial clearance processes.
A group of autoinflammatory disorders called cryopyrin-
associated periodic syndromes or CAPS results from mutations 
associated to the NALP3 inflammasome (10). CAPS encompass 
three distinct autoinflammatory conditions, including familial 
cold autoinflammatory syndrome (FCAS), Muckle–Wells 
syndrome (MWS), and neonatal onset multisystemic inflamma-
tory disease/chronic infantile neurological cutaneous articular 
syndrome (NOMID/CINCA). These conditions form a spectrum 
of diseases of increasing severity, from the mildest FCAS to the 
most severe (NOMID/CINCA). The symptoms of CAPS include 
recurrent fever, urticarial-like rash, arthralgia and/or arthritis, 
amyloidosis, and ocular involvement.
Interestingly, NLRP12 displays sequence and structure similar-
ity to NLRP3 and plays a crucial role in immune system mechanisms 
against pathogenic agents (11). As CAPS-like disorders, NLRP12-
associated disease can be induced by generalized exposure to cold 
and is characterized by recurrent fever episodes accompanied by 
skin rash, lymphadenopathy, and abdominal pain.
At protein structural level, the NLR proteins bear some simi-
larities, as a centrally located NACHT domain and C-terminal 
LRR domains. A multiple sequence alignment reported by 
Albrect and colleagues have indicated a conserved structural 
core of the NACHT domain residues and reported an identi-
cal mutation at analogous position in NLRP3 and NOD2 (12). 
The mutations p.R260W in NLRP3 and p.R334W in NOD2 are 
described in literature as associated with FCAS/MWS and BS, 
respectively. The replacement of the positively charged Arginine 
with an hydrophobic Tryptophan results at protein level in a dif-
ferent environment that may impair the folding and the function 
of the NACHT domain. The p.R260W mutation is considered a 
frequent or unambiguous CAPS-linked mutation and has been 
shown in vitro to provoke spontaneous activation of the NLRP3 
inflammasome (13). According to previous descriptions, the 
p.R260W mutation is associated with exanthematous rash, joint 
symptoms, and sight impairment, while fever is unusual. The 
position 334 in NOD2 protein instead is considered a hot spot for 
mutations since the majority of described BS-mutations involves 
this evolutionary conserved region (9). Clinical manifestations 
varied even among familial cases with p.R334W, but it tended to 
cause more obvious visual impairment.
We personally notice other identical mutations located at the 
same alignment position (Figure 1A). The mutations p.D303N in 
NLRP3 and p.D383N in NOD2 presented all clinical criteria of 
the associated diseases, CINCA/MWS, and BS, respectively (14, 
15). The substitution of the negatively charged Aspartic acid with 
a non-charged Asparagine may alter the folding in the NACHT 
domain. The mutations p.E304K in NLRP3 and p.E383K in 
NOD2 are known to be associated with CINCA and BS, respec-
tively. The substitution of the negatively charged Glutamate with 
a positively charged Lysine may alter a fine-tuned regulatory 
mechanism linked to ATP hydrolysis in the NACHT domain. 
The p.E304K variation has been predicted as disease-causing 
mutation, based on position in the protein, molecular nature, 
and evolutionary conservation of the residue changed (16). It is 
associated with rash, persistent arthritis, and uveitis but without 
fever. The p.E383K mutation is known to impair the function of 
NOD2 but without a primary mediation of IL-1β and other pro-
inflammatory cytokines (17). Clinical manifestations associated 
with p.E383K are papulonodular skin eruption, mild arthritis of 
the hands and feet, and severe chronic bilateral uveitis, evolving 
in panuveitis.
Based on in silico analysis reported by Jéru et al. (11), we have 
observed a mutation affecting the same residue at analogous 
position in the structural core of the NACHT domain of NLRP3, 
NLRP12, and NOD2 (Figure  1B). The mutations p.W408X in 
NLRP12, p.W414L in NLRP3, and p.W490L in NOD2 are known 
to be associated with FCAS, MKW, and BS, respectively. The substi-
tution of the aromatic Tryptophan with a aliphatic Lysine may alter 
the formation of hydrogen bonds in the NACHT domain. The stop-
gain mutation (p.W408X) may instead lead to protein dysfunction 
and, therefore, contribute to disease pathogenesis. This nonsense 
mutation in NLRP12 is found associated with recurrent fever and 
skin urticaria due to cold conditions (18). The other variations have 
been reported as AID-causing mutations in Infevers database (19).
Identical mutations at analogous conserved sequence posi-
tions are extremely improbable to occur by chance. It is also 
improbable that a mutation affecting the same residue in a highly 
FiGuRe 1 | (A) Multiple sequence alignment of NOD2 (NP_071445.1) and nod-like receptor protein 3 (NLRP3) (NP_001230062.1) in the central portion of NACHT 
domains by means of CLUSTAL Omega (EMBL-EBI). Alignment with NLRP12 (NP_653288.1) is also presented in (B). The asterisk (*) indicates positions with a 
single, fully conserved residue. The colon (:) indicates a strong conservation of residues with strongly similar properties, while the period (.) marks residues with 
weakly similar properties. Red circles highlight the mutations at the same position in the alignment (p.R334W/p.R260W; p.D382N/p.D303N; p.E383K/p.E304K; 
p.W408X/p.W414L/p.W490L).
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conserved sequence regions of a protein family is a fortuitous 
event. In fact, there is also a good identity percentage between 
NOD2 and NLRP3 sequences (26.72% complete identity and 
18.30% of strong similarity) and NLRP3 and NLRP12 sequences 
(49.89% complete identity). Common clinical manifestations are 
also reported for the identical mutations, i.e., the absence of fever, 
the increased ocular involvement, and skin rash in the variations 
presented above. These findings suggest a close relationship 
between BS, CAPS, and NLRP12-associated disease, not only 
because both disorders affect the innate immune system but also 
because of common evolution.
Investigation of the mechanisms that generate duplicate gene 
copies and the subsequent dynamics among gene duplicates 
represent a potential area for shedding light on evolutionary 
aspects related to interactions among all AIDs. From our point of 
view, the mechanism of gene duplication could help to explain the 
overlap of clinical symptoms and the great genetic heterogeneity 
in AIDs. We expect that the exponential increase in genomic data 
and rapid advances in molecular genetic technology will provide 
more evidence to support our hypothesis.
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